CADS Framework Provides Error-Controlled Evaluation for Biological LLM Proposers
October 20, 2026
CADS utilizes capped likelihood-ratio bounds and e-processes to measure the incremental value of LLM proposers in sequential biological screens. The framework controls the terminal false discovery rate under adaptive sampling and corrupted readouts, preventing the overestimation of LLM utility in experimental loops.
HOW THIS AFFECTS YOU
●
researcherYou can use this to ensure your agentic discovery loops aren't just benefiting from algorithmic harness capacity.
●
healthThis provides a more rigorous way to validate AI-driven drug discovery and biological screening protocols.